CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands |
6 Months Ended |
Apr. 29, 2018 |
Apr. 30, 2017 |
| Cash flows from operating activities: |
|
|
| Net income (loss) |
$ (435)
|
$ 19,013
|
| Adjustments to reconcile net income (loss) to net cash from operating activities: |
|
|
| Depreciation and amortization |
20,800
|
20,378
|
| Amortization of deferred financing costs |
781
|
954
|
| Loss on extinguishment of debt |
21,875
|
0
|
| Share-based compensation expense |
7,868
|
5,862
|
| Gain on insurance recovery |
0
|
(9,601)
|
| Loss on disposition of business |
6,192
|
0
|
| (Gains) losses on assets, net |
(250)
|
262
|
| Provision for doubtful accounts |
(44)
|
1,406
|
| Benefit for deferred income taxes |
(1,676)
|
(113)
|
| Changes in operating assets and liabilities, net of effect of acquisitions and dispositions: |
|
|
| Accounts receivable |
17,060
|
12,232
|
| Inventories |
(24,920)
|
(8,617)
|
| Income taxes |
(2,822)
|
982
|
| Prepaid expenses and other |
(4,182)
|
(1,875)
|
| Accounts payable |
12,686
|
(21,737)
|
| Accrued expenses |
(12,016)
|
(11,068)
|
| Other, net |
(931)
|
(189)
|
| Net cash provided by operating activities |
39,986
|
7,889
|
| Cash flows from investing activities: |
|
|
| Capital expenditures |
(16,897)
|
(11,556)
|
| Proceeds from sale of property, plant and equipment |
2,678
|
2,533
|
| Business disposition, net |
(4,415)
|
0
|
| Proceeds from insurance |
0
|
420
|
| Net cash used in investing activities |
(18,634)
|
(8,603)
|
| Cash flows from financing activities: |
|
|
| (Deposit) refund of restricted cash |
(41)
|
240
|
| Proceeds from stock options exercised |
1,040
|
1,196
|
| Proceeds from ABL facility |
65,000
|
35,000
|
| Payments on ABL facility |
(65,000)
|
(35,000)
|
| Proceeds from term loan |
415,000
|
0
|
| Payments on term loan |
(144,147)
|
(10,000)
|
| Payments on senior notes |
(265,470)
|
0
|
| Payments on note payable |
(441)
|
(458)
|
| Payments of financing costs |
(6,275)
|
0
|
| Payments related to tax withholding for share-based compensation |
(4,612)
|
(2,389)
|
| Purchases of treasury stock |
(46,705)
|
(3,533)
|
| Net cash used in financing activities |
(51,651)
|
(14,944)
|
| Effect of exchange rate changes on cash and cash equivalents |
(24)
|
(63)
|
| Net decrease in cash and cash equivalents |
(30,323)
|
(15,721)
|
| Cash and cash equivalents at beginning of period |
65,658
|
65,403
|
| Cash and cash equivalents at end of period |
$ 35,335
|
$ 49,682
|